Recombinant Transferrin (Holo‑Form) ART202S

Anrate | Standardized Holo‑Recombinant Iron Carrier Supporting Process Scale‑Up & Commercial Mass Production of Biopharmaceuticals

Four Core Advantages Addressing Key Challenges of Industrial Mass Production

1. Animal‑Free Recombinant Process for Global Regulatory Compliance

   
   

   Produced entirely via genetically engineered fermentation, it contains no plasma, serum or other animal‑derived substances, fundamentally eliminating risks of blood‑borne viruses, mycoplasma and heterologous protein contamination. Fully aligned with domestic and international pharmaceutical regulatory standards, it can be directly applied to IND/BLA filings, commercial production and overseas project deployment. It enables independent control of core raw materials and mitigates compliance risks.
   
   
2. Fixed Holo‑Structure Reducing Process Variables & Scale‑Up Risks

   
   

   With a standardized holo‑saturated structure and fixed iron‑ion binding ratio, no extra iron concentration adjustment is needed. Directly compatible with diverse large‑scale serum‑free and low‑serum culture systems, it significantly minimizes formula variables, avoids quality fluctuations during process scale‑up, shortens mass‑production validation cycles and cuts process R&D costs.
   
   
3. High‑Purity Stable Quality Control with 5‑Year Ultra‑Long Shelf Life for Bulk Stocking

   
   

   HPLC‑RP testing confirms purity ≥98.0%. The dry powder dissolves rapidly with long‑term stable protein activity. Manufactured under standardized GMP quality control, it delivers excellent batch‑to‑batch consistency. Stored sealed and light‑proof at 2–8 °C with a 5‑year shelf life, it supports bulk inventory and medium‑to‑long‑term production planning for continuous stable operation of production lines.
   
   
4. Native Human‑Derived Activity Improving Production Efficiency Across Multiple Cell Platforms

   
   

   It fully retains physiological functions of human transferrin for efficient iron‑ion transport and supply, along with antioxidant, anti‑apoptotic and bacteriostatic properties. Widely applicable to mainstream culture systems including CHO cells, CAR‑T cells, stem cells and primary cells, it effectively improves cell expansion density and viability, increases expression levels of antibodies, recombinant proteins and other target products, and optimizes overall production efficiency.
   
   

Product Specifications

• Product Name: Recombinant Transferrin (Holo‑Form) ART202S
• Grade: Cell Culture Grade / Industrial Production Grade
• Purity: ≥98.0% (HPLC‑RP)
• Standard Packaging: 1g, 10g, 100g; kilogram‑scale customized mass production available
• Minimum Order Quantity (MOQ): ≥100g
• Storage: Sealed and protected from light at 2–8 °C, 5‑year shelf life
• Applications: Large‑scale antibody drug production, industrial‑grade CAR‑T cell preparation, stem‑cell drug R&D, commercial vaccine manufacturing, large‑scale serum‑free medium application, etc.

Choose ART202S to Boost Industrial Upgrading of Biopharmaceuticals